Previous 10 | Next 10 |
INOVIO Reports Inducement Grants Under Inducement Plan PR Newswire PLYMOUTH MEETING, Pa. , Sept. 1, 2022 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect pe...
INOVIO to Present at the H.C. Wainwright 24th Annual Global Investment Conference PR Newswire PLYMOUTH MEETING, Pa. , Aug. 30, 2022 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to he...
Inovio Pharmaceuticals ' (NASDAQ: INO) stock rose by more than 18.5% as of 2:30 p.m. ET on Wednesday after the company's Q2 earnings results broke the news of its plans to restructure its operations to conserve cash. The biotech will lay off 18% of its full-time employees while addi...
Image source: The Motley Fool. Inovio Pharmaceuticals (NASDAQ: INO) Q2 2022 Earnings Call Aug 09, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Inovio Pharmaceuticals (INO) Q2 2022 Earnings Call Transcript
Inovio Pharmaceuticals, Inc. (INO) Q2 2022 Earnings Conference Call August 09, 2022, 16:30 ET Company Participants Thomas Hong - IR Jacqueline Shea - CEO, President & Director Michael Sumner - Chief Medical Officer David Liebowitz - SVP, Clinical Developm...
Inovio Pharmaceuticals ( NASDAQ: INO ) beat on the top line but fell short on the bottom line in its Q2 2022 results as net loss widened 32% compared to the prior-year period to ~$108.5M. Net loss, basic and diluted, was -$0.46 compared to -$0.39 basic and diluted in Q...
Inovio Pharmaceuticals press release ( NASDAQ: INO ): Q2 GAAP EPS of -$0.46 misses by $0.15 . Revenue of $0.78M (+188.9% Y/Y) beats by $0.26M . INOVIO's projections to extend its cash runway into the third quarter 2024 include its cash burn estimate of approxim...
INOVIO Reports Financial Results and Highlights for the Second Quarter 2022 PR Newswire Increased Cash Runway into Third Quarter 2024 with Cost-Savings and Corporate Restructuring Efforts Strengthened Executive Team with Appointment of Dr. Michael Sumner as C...
INOVIO to Report Second Quarter 2022 Financial Results on August 9, 2022 PR Newswire PLYMOUTH MEETING, Pa. , July 26, 2022 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help protect...
Zymergen ( ZY ) +40% on $300M buyout deal with Ginkgo. Chimerix ( CMRX ) +30% sounds alarm over current outbreak. FaZe Holdings ( FAZE ) +28% . Infrastructure and Energy Alternatives ( IEA ) +26% to buy IEA in cash-and-stock deal value...
News, Short Squeeze, Breakout and More Instantly...
Inovio Pharmaceuticals Inc. Company Name:
INO Stock Symbol:
NASDAQ Market:
Inovio Pharmaceuticals Inc. Website:
Inovio Receives Advanced Therapy Medicinal Product Certificate from European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate INO-3107 PR Newswire Data reviewed complies with standards that would be used to evaluate an EU Marketing Authorization Applic...
INOVIO to Report Second Quarter 2024 Financial Results on August 8, 2024 PR Newswire PLYMOUTH MEETING, Pa. , July 25, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and ...
5G leader welcomes new Chief Product Officer, Senior Vice President Sales/Service Providers and Head of Operations Inseego Corp. (Nasdaq: INSG), a technology leader in 5G mobile and fixed wireless solutions for mobile network operators, Fortune 500 enterprises, and SMBs, today announced...